The Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of HEC88473 in Healthy Subjects
Clinical trial NCT04829123 · COMPLETED
Trial details
- NCT number
- NCT04829123
- Sponsor
- Dongguan HEC Biopharmaceutical R&D Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-14
- Primary completion
- 2022-03-02
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.